The 14th World Congress of Hair Research was recently held in Seoul, South Korea. As the world’s leading academic summit in the field of hair science , this congress brought together top scholars and industry leaders from multiple countries. Vichy, a brand under the L’Oréal Group, partnered with hair expert Professor Wu Wenyu to release landmark clinical research findings, setting a new benchmark for a comprehensive scalp health management model.
A significant challenge to hair transplant surgery.
Studies have shown that androgenetic alopecia (AGA) is a common type of hair loss in clinical practice, with a significant proportion of patients also suffering from seborrheic dermatitis of the scalp (SSD). The persistent inflammation, increased dandruff, microecological imbalance, and damaged skin barrier caused by seborrheic dermatitis are akin to “barren and disease-prone soil.” If traditional hair transplant surgery neglects systematic management of scalp health during the perioperative period , postoperative problems such as infection, folliculitis, and worsened itching and swelling may occur, directly affecting the timing of the surgery, the survival rate of transplanted hair follicles, and the final surgical outcome. How to create a healthy scalp environment for these patients has been a challenging problem for clinicians for many years.
Focusing on perioperative management of hair transplantation: Research findings on comprehensive solutions
Professor Wu Wenyu’s research focuses on the perioperative management of hair transplant patients with seborrheic dermatitis (SSD). A controlled experimental design was used, including hair transplant patients with SSD. The experimental group received a phased “holistic scalp management program” during the perioperative period, centered on an anti-dandruff agent containing selenium sulfide and salicylic acid. This program encompassed effective shampoos and conditioners during the preoperative intervention, postoperative repair, and long-term maintenance phases. The control group used only standard shampoos and conditioners. The study systematically evaluated the holistic approach’s effects on scalp health, barrier repair, and hair transplant outcomes by tracking multiple postoperative time points, including SSD scores, transepidermal water loss (TEWL), terminal and vellus hair density, terminal hair ratio, vellus hair ratio, hair diameter, and patients’ subjective symptoms.
Early research data indicates that, compared to the control group, the holistic management approach can significantly control scalp inflammation and dandruff, optimize the skin microecological balance, enhance skin barrier function, and promote postoperative wound healing; it can also reduce the incidence of postoperative erythema and pain, thereby helping to improve the postoperative experience of hair transplant patients. This study is still under further follow-up.
Vichy Green Label: A powerful tool for perioperative scalp health management driven by core ingredients.
Vichy Green Label Anti-Dandruff Shampoo is precisely formulated with multiple active ingredients, including 1% selenium sulfide, 0.9% salicylic acid, vitamin E, and ceramides. Selenium sulfide powerfully inhibits the excessive proliferation of Malassezia, reducing dandruff and inflammation at its source; salicylic acid gently exfoliates accumulated keratin, unclogs hair follicles, and prevents post-operative folliculitis; vitamin E and ceramides soothe inflammation and repair the skin barrier. These multiple ingredients work synergistically to target the core pathology of seborrheic dermatitis—controlling inflammation and microecological imbalance while simultaneously strengthening the scalp’s own defenses.
For patients in the perioperative period of hair transplantation, Vichy Green Label Anti-Dandruff Shampoo provides a non-drug, topical, and highly effective adjunctive treatment. Without increasing the burden of systemic medication, it significantly improves the scalp environment, creating a stable, clean, and low-inflammatory environment for hair follicle colonization and growth, thereby helping to increase the final success rate of hair transplantation surgery. It fills the gap in the current lack of standardized and effective scalp care products for perioperative scalp management.
From Clinical to Universal: Defining the Future of Scalp Health Through Science
In the past, doctors and patients often focused on the surgical procedure itself; now, Professor Wu Wenyu’s team, together with Vichy, has proposed and implemented a holistic management model of “preoperative conditioning – intraoperative operation – postoperative care – long-term maintenance,” providing a scientific and accessible rehabilitation path for hair loss patients with seborrheic dermatitis.
Vichy is driven by both clinical needs and scientific innovation, translating experimental evidence into scalp health solutions that benefit the general public. Moving forward, Vichy will continue to collaborate with global hair experts to drive the development of the hair health field!
Media ContactCompany Name: Ruder Finn GroupContact Person: Anastasia WangEmail: Send EmailCity: ShanghaiCountry: ChinaWebsite: https://www.vichyusa.com/
